Stocksigma LogoStocksigma Logo

Morepen Labs FY26 BRSR: INR 1,676.66Cr Turnover With 9.39% ESG Capex Allocation

Morepen Laboratories reported operational turnover of INR 1,676.66 crore and a net worth of INR 1,245.41 crore for the year ended 31st Mar'26

Morepen Labs FY26 BRSR: INR 1,676.66Cr Turnover With 9.39% ESG Capex Allocation

Morepen Laboratories Ltd 路 Others (Uncategorized) 路 02 Sept 2026, 6:58 pm

Morepen Labs FY26 BRSR: INR 1,676.66Cr Turnover With 9.39% ESG Capex Allocation Morepen Laboratories reported operational turnover of INR 1,676.66 crore and a net worth of INR 1,245.41 crore for the year ended 31st Mar'26. Revenue was primarily driven by the API segment (56.33%) and Medical Devices (35.60%), with exports comprising 40% of total turnover. Highlighting its ESG focus, the company allocated 9.39% of total capex towards environmental initiatives, including a 955-KW solar plant and zero-liquid-discharge systems. Furthermore, Morepen achieved an EcoVadis Bronze Medal (score 70), reinforcing its sustainability profile to support international market expansion.

Original exchange filing (PDF)

More announcements from Morepen Laboratories Ltd

All Morepen Laboratories Ltd announcements